Business Disposal: GSK Dumps Affymax

Published on: 

Pharmaceutical Executive

Pharmaceutical Executive, Pharmaceutical Executive-09-01-2001, Volume 0, Issue 0

London-Following a review of its own drug discovery capabilities, GlaxoSmithKline practically gave away its majority stake in Affymax to a group of venture capitalists led by Patricof.